Skip to main navigation Skip to search Skip to main content

Findings from Gyeongsang National University Hospital in Personalized Medicine Reported (Therapeutic Targeting of the Galectin-1/miR-22-3p Axis Regulates Cell Cycle and EMT Depending on the Molecular Subtype of Breast Cancer)

Press/Media

Period6 Mar 2025

Media coverage

1

Media coverage

  • TitleFindings from Gyeongsang National University Hospital in Personalized Medicine Reported (Therapeutic Targeting of the Galectin-1/miR-22-3p Axis Regulates Cell Cycle and EMT Depending on the Molecular Subtype of Breast Cancer)
    Media name/outletNewsRx Women's Health Daily
    Country/TerritoryUnited States
    Date6/03/25
    PersonsYeon Ju Kim